CHOLESTEROL GHOST EVERYWHERE
Prof. B. M. Hegde,
Vice Chancellor,
MAHE University,
MANIPAL-576 119.
This white, powdery, odourless and waxy substance
does not even have any taste, but causes so much trouble for almost all those who have the
habit of reading today's health magazines. It does not cause so much havoc for human
health as it does to human happiness, as no literate man, woman or child escapes its
horrors in print and electronic media. The headlines scream: "Cholesterol is one of
the three controllable risks for heart attacks"-"You could be the next person to
get the heart attack"-"Heart attacks are the biggest widow makers" etc. In
addition, the Task Force on cholesterol screening divides human levels as desirable,
borderline high and high. Who can escape the mental torture of all this propaganda?
Where is the truth? Truth always is the casualty
when money business gets into any field, medicine not excluded. The business of
cholesterol research and the cholesterol lowering drugs runs into billions of dollars. As
Professor Pickering wrote years ago about the business of anti-hypertensive drugs, more
people make a living off cholesterol than
dying of it. Some of the researchers have built their empires on this substance. They are
the same people who sit in committees of research, or the watch dog bodies overseeing
research and also in the advisory panels (pay roll) of big drug companies. They are the
ones who make the rules for screening, testing, research grant giving and also drug advice
to patients and their doctors. This is a close knit circle of fellow travellers!
There are a few who see through their game but do
not have the money, time and also the academic support to
pursue their intuition further into the complicated research web that the vested
interests have woven around them to protect themselves with that magic word
"science". Occasional ones who dare to take them head on are being frustrated.
In their heartland, the USA, a layman declared war on the establishment by publishing a
direct assault on the academia in the national press ten years ago. He was Thomas Moore.1 Interestingly a practicing cardiologist,
Randall Marsh, from Greeley in Colorado wrote to support Moore's contentions ten years
later.2 I wonder how many of you have read my repeated assaults on the
cholesterol myth in many of my writings, books and innumerable medical talks to the
establishment, long before Moore, both in India and abroad. Most of the readers take me to
be a "therapeutic nihilist" or a cynic. Drug companies have an eye on me.3
The fundamental economics of all this boils down
to the fact that anti-hypertensive and
anti-cholesterol drugs are the two classes of drugs that the hapless victims have to take
for the rest of their lives, a good business proposition for the drug manufacturers. Rest
of the drugs are used to treat symptoms of diseases and they are used for a short time and
when the symptoms disappear they are no longer used. So the companies bend over backwards
to sell the former two classes of drugs. The latest craze in America is in the vitamin
market. They are also to be taken life long from childhood to the time of death. Most of
the companies are in this business. Every house has a large stock of all kinds of
vitamins, although studies have shown that these do not do much good compared to extra
intake of fruits and vegetables. The latter have many other hidden anti-oxidants in them
compared to the known A,C, and E vitamins sold in the pills.
In fact, I am only worrying about the millions of
people who fall a prey to the blatant misuse of the academic machinery that pours fourth
half truths, falsehoods and fearful misrepresentation of the truth in this field. May be
they believe in the old saying that a lie repeated thousand times could be passed off as
truth. "Truth could influence only half a score of men in a century while falsehoods
and mystery will drag millions by the nose", said Aristotle centuries ago. Having met
with Marsh recently and having studied Thomas Moore carefully, I think time has come for
me to update the readers in this field.
Cholesterol is found in all foods of animal
origin. There is no cholesterol in anything vegetarian. It is an integral part of the
animal cell wall. If one remembers that millions of cells die everyday in the human body
to be replaced by new ones, one would quickly realize the importance and need for
cholesterol for man. Various hormones in the body are manufactured from cholesterol. Even
if one does not eat cholesterol at all, human liver could make enough for the body's
needs. 90% of the total cholesterol is made inside our liver and only 10% of it comes from
the diet. Since cholesterol does not dissolve in water its transport inside the body needs
a vehicle. The latter is usually the protein package-the lipoprotein. Cholesterol is found
in all major lipoproteins, the Low Density Lipoprotein (LDL) and the High Density
Lipoprotein (HDL).
Usual range of normal cholesterol has been, since
my college days, between 150-250 mg per
deciliter. Recently the American bosses of cholesterol research thought it fit to change
this time honoured normal range by declaring three levels
for humans thus:4
less than 200
mg/dl.................DESIRABLE.
200-239 mg/dl.........................BORDERLINE-HIGH.
More than 240 mg/dl...............HIGH
The story behind this is intriguing. My hunch is
that there are at least 50-60 million Americans in the normal range of 200-250 mg, who by
the above classification are not only frightened out of their wits, but come under the net
for life long anti-cholesterol drug therapy. With the present drugs being sold at such
phenomenal prices the catch would not be less
than 10 billion dollars per year for the drug companies. Apart from this there does not
seem to be any other valid reason in the medical literature to support this new found
wisdom on the part of the cholesterol pundits!
Americans are tormented by reports that swear
that if only every one of them either ate very low fat diet or took the wonder drugs to
lower their cholesterol levels they would survive for all times. If not 30% of the two
million deaths in America per year due to heart attacks would eat them up as well. The
pamphlets tell them "THE ARTERIES BECOME NARROWER AND
NARROWER, MUCH AS OLD WATER PIPES BUILD UP SCALY MINERAL DEPOSITS".
This analogy also helps another money spinner of
coronary revascularisation. Lay people think that blocked coronaries are like blocked
toilet pipes to be bypassed. Never do they realize
that the body has its own wisdom to compensate for those long standing blocks, many of
which start in early childhood, by providing collateral vessels and also remodeling the
blocked vessels.
The blood supply to the heart muscle does not as
much depend on the blocked four large coronaries on the surface of the heart that your
doctor shows you on the x-ray(angiogram) as it does on the capacity of the millions of
small vessels going directly into the muscle of the heart having a wide capacity to dilate
excessively in case of reduced supply from the larger vessels. This Flow Fraction Ration (FFR) is called CORONARY RESERVE, the latter could vary from one
to another, the large surface vessel patency notwithstanding!
It is not the science of medicine that is bad but
it is the "scientist" that twists the facts to suit his convenience that is bad
and is the pain in the neck. Thomas Moore was bold enough to take them head on. Years
later he was joined by the American College of Physicians (ACP) who had their own
guidelines-much more saner than the horrendous guidelines of the Task Force- the Force put
together to fight the cholesterol war-may be against the gullible public!5 The
ACP guideline tried to correct the mistake done by the task force, but was severely
criticized by the latter in no uncertain terms. If an equally qualified body like the ACP
could come forward to rubbish the earlier guidelines on their own turf without much
success, lesser mortals like me and Mr.
Moore have very little hope of succeeding in our uphill task. But fight we must for the
truth to come out. Here are the facts for all to see.
In the late eighty's a thinking American
cardiologist, and a respected one at that, Eliot Corday, wrote an article in the American
College of Cardiology Journal warning his colleagues about the fallibility of the task
force guidelines. He said " if one were to very strictly follow the guidelines and
eat no fat at all or take drugs to lower his cholesterol all his life, one could hope to live only for three days to three months extra
on this planet!" Another great British expert on cholesterol, and a most
respected one at that, Sir Michael Oliver, was so upset about the task force
misrepresenting the Transatlantic Consensus
Conference Data, wherein he was an important invited member, wrote an editorial in The Lancet, after coming back from the USA,
entitled "Consensus or Non-senses Conference."
Let us look at the genesis of this myth.
Lowering your cholesterol is next
to impossible with diet, and often dangerous with drugs-and it wont make you live
any longer said Thomas Moore
in his article in the September 1989 issue of
The Atlantic.
One morning in early October 1987 The US Health
Department made a significant announcement that 25% of the US adult population had a very
dangerous condition that has no symptoms, needing urgent medical treatment. Since there
were no symptoms there is need to screen the whole population to identify those in
danger. One in four adults would be on drugs for the rest of their lives. This was called
the National Cholesterol Education programme.
At this stage no unequivocal evidence existed in
science that lowering cholesterol would save lives! The National Heart, Lung, and Blood
Institute must have spent about $ 300 million to get to this inconclusive stage of
research. The total human subjects involved in research was a staggering 3,61,622 men and
60% of the Institutes budget! At that point
in time the only drug available was potentially dangerous and had no track record at all
(Cholestyramine). In addition, the testing laboratories, even controlled by research
bodies, could not deliver identical cholesterol reports, not to speak of the thousands of
laboratories in the periphery.
Nations clinical laboratories
performance was so poor that millions of normal people were labeled high cholesterol
victims. wrote Moore.
This drama began in 1951 when Pentagon dispatched
a team of pathologists to Korean war zone to study the autopsies of the young soldiers who
were killed in the war. A large percentage of them had blocks of the coronary vessels at
the young age of 22 years. This report by Major William F. Enos and Lieutenant Colonel
Robert H. Holmes was the beginning of this sordid cholesterol drama. In Europe it had
started after the second world war. 77% of the Korean war victims at the tender age of 20
had severe coronary artery blocks, which by todays x-ray standards, would have
warranted coronary artery bypass surgery. They were all very fit to be in the American
army though and were unfortunately killed by the bullet!
Another drama was unfolding in yet another set
up. Epidemiology has served medical science very well in detecting the cause of epidemics
of infectious diseases. Cholera in London, typhoid Mary and many other examples could be
given here. The same epidemiology applied to chronic degenerative diseases tells nothing
about whether a particular person gets a particular disease; but it may identify groups of
men at risk. However this was overlooked in all epidemiological diseases and today epidemiologists at times cause epidemics!
Such a scenario started in a remote small town of
Framingham in Massachusetts way back in 1948.The Framingham experiments now being quoted
everywhere in the world, built a detailed portrait of coronary artery disease
from a very small sample of just 5,127 adults, of whom 404 died of heart attacks over a
period of twenty-four years! There were so many loopholes that even the medical profession
is not aware of. Many of the people did not come for regular check ups, the laboratory
reports were not controllable over such a long period of time, while major changes took
place in the laboratory technics themselves, so that their uniformity was lost completely.
Although it was a sound study, its limitations in projecting it on to the world population
are phenomenal, to say the least. While tidy
mathematical charts and graphs using linear mathematics tell the tale of Framingham for
lectures, lot of medical guess work went into the final conclusions.6, 7
A series of risk factors emerged out of this
study, almost all of which have been shown to have no predictability for the future even
for groups, leave alone individuals. Two of the major risk factors could never be changed- male sex and old age! So
the war against all the minor and relative risk factors began from then on; one of them
being the ghost of cholesterol which haunts every one even to this day, based on a study
whose scientific validity is open to question. Advertisements, newspaper articles, books,
and television talk shows kept up the tempo all over the world.
Life depends on cholesterol. All the life giving
substances are derived from that chemical and that is why it is found in abundance in a hens egg.
While it is true that all studies showed a direct relationship between rising cholesterol
and heart attacks they also showed that extensive and fatal heart attacks could occur even
in those with low cholesterol.
Be that as it may, the variations from laboratory
to laboratory, even in the small group of research laboratories of the Task Force, were
significant. The time of the day, the way blood is collected, whether taken sitting or
supine, how long after collection was the analysis done, and even using diluants in blood,
the diet that the patient was on just before taking blood and, of course, the laboratory
which does the testing, could all change the results
by as much as 10-18%. That, in itself, would make a man go from low to dangerously
high levels, creating anxiety strong enough to provoke a heart attack!
The above statement does not take into
consideration the quality of laboratories in the far flung areas of the world. Dr. D.M.Hegsted, of Harvard University, showed that a
variation of 5-9% in serum cholesterol levels even in hospitalized patients, on uniform
diet, was not unusual! The sub-fraction
measurement of HDL and LDL was of no significance for use in clinical setting as shown by
a group of researchers in Stanford where they found that 39% of the laboratories tested
showed an error rate of 31%.
Then started the saga of lowering
elevated cholesterol in the population. First attempts were by diet
control. Very soon studies done even by the Framingham study group concluded: There is, in short, no suggestion of any relation
between diet and the subsequent development of coronary disease in the study group. We have many other studies subsequently
giving varied conclusions. Even the Heat-Diet
Pilot of 1971 did not achieve significant success.
Then started the intervention trials with
drugs. To sum up, all of them while showing a fall in fatal and non-fatal heart attacks in
those whose cholesterol levels were significantly lowered by drugs, also showed a higher
total death in the treated cohorts. The largest and the most expensive of them
was the MRFIT study which cost $ 115 million and involved 250 researchers. The following
facts emerged.8
* | Behaviour of large groups of people could be
changed. |
* | Drastic changes that the participants were made to
make in their diets did not have any effect on the levels of cholesterol in their blood. |
* | No significant difference in deaths could be
found in the treated group and the control
after nine years of follow up as on 28th
February 1982. |
* | In fact, slightly more deaths occurred in the
treated group! |
* | In the control group deaths from heart
attacks were 40% lower than expected in the beginning, showing how fallacious future
predictions in linear mathematics could be.
Doctors have been predicting the unpredictable. |
At this point in time there was no scientific
validity for all the advice given to patients. More studies followed. Another mile stone
and expensive study was the Coronary Primary Prevention Trial (CPPT).
It screened 4,80,000 middle aged men to select 3,810 subjects for this study over a period
of three years. Cholestyramine was the drug used in this study, but even the placebo used
did have side effects. The drug, of course, had significant side effects. In Europe
clofibrate was being used at the same time for the first large study, The Newcastle
Edinburgh Study. CPPT and the MRFIT together cost the NIH a total of $ 494 million
dollars! The CPPT trial did not show any
significant benefit in the treatment group compared to the control group at 99% or even at
95% significant levels. Instead of admitting that, the researchers went in for a less
exacting one-tailed test to compare the groups and came up with the startling
statement that the study leaves little doubt
about the benefit of cholestyramine therapy. 9
Although there were dissenting voices at that
stage, the Heart Institute went ahead and bulldozed the population with the National Cholesterol Education Programme. The
American Medical Association and many drug companies assisted the Heart Institutes
efforts. While we believe that lowering ones cholesterol is good there are
disquieting reports that lowered cholesterol levels could be associated with cancer.10
While there is a possibility that it could be due to the original cancer itself, studies
have shown low cholesterol levels in those who developed cancer even after 5-7 years. Japanese studies have also shown a higher rate of
stroke in people with very low cholesterol levels.
Many powerful drugs have come on the scene since
then, but almost all of them showed a higher total death at the end of the day in treated
groups compared to the controls.11,12,13 The latest are the statins. They have
not been there for long enough to be really tested like their predecessors. Among the
cholesterol-synthesis inhibitors like lovastatin, were triparanol and compactin. The first was withdrawn
hastily because it produced severe side effects like rapid cataracts, severe skin rashes
and heavy loss of hair. Compactin was also withdrawn under a veil of secrecy, but thought
to have given rise to high cancer rate in dogs. Europe had by then gone ahead with another
drug Gemfibrozil with the same results- good effect on the cholesterol levels in the
laboratory reports but slightly higher death rate in the treated group!
The original screenees of the MRFIT study have
been followed up, all 3,61,662 of them by a group led by Jeremiah Stamler at the
Northwestern University, 70 times larger than the Framingham data and people coming from
eighteen US cities. Although the data here are not reliable as it depended on death
certificates it did show that the hazards of high cholesterol are, if anything, only
modest. The study, however, put out one statement which is being used and reused by all
and sundry all over the world. The statement goes thus: Each one per cent reduction in cholesterol will lead
to two percent reduction in death due to coronary disease. The truth is that this result was never seen in this study. What was
observed was: For each one percent increase
in cholesterol level the risk of coronary disease could go up by two percent. 1
The difference in these two statements is like the difference between lightening and the
lightening bug!
Much water has flown under the bridge since these
studies and there have been many more small big and medium studies carried out in many
other parts of the world, but even today the wisdom of the medical profession could be
summed up in the words of Eliot Corday in his
article in the Journal of the American College of Cardiology in 1989.
* | Cholesterol should be checked only if there are
sound clinical indications. |
* | A mixed diet low in calories and saturated fat
should be recommended along with some physical exercise. |
* | It is irresponsible to force public into a costly
cholesterol reducing programme without firm scientific evidence. |
To that I add mine:14 |
|
* | Do not rely on one reading of the fat profile, check at least five to six times from different laboratories, if the original result was high. |
* | Indian vegetarian diet without much fried foods and
other saturated fats and low salt is the ideal one for most people. |
* | Avoiding alcohol and tobacco is as important if not
more important than worrying about cholesterol |
* | Recent studies show the mind and its effects on the
heart as more important risk factors than all the above mentioned ones. Keep your mind at
peace. Hostility and depression are real culprits for heart attacks. |
* | Future prediction, using linear mathematics, as we
do now in medicine is only a part time job, as the rest of the time you will have to try
and keep your foot out of your mouth. |
* | Epidemiology does not tell us who in society would
get any disease, as time evolves. |
Acknowledgement:
I am grateful to Prof. Bryan Cooke of the
University of Northern Colorado, for getting me the article by Thomas Moore and also
introducing me to Dr. Randall Marsh.
BIBLIOGRAPHY.
1) | Moore TJ . The Cholersterol Myth. The Atlantic 1989 September. |
2) | Marsh R. Comments on Moores Paper. January
2000. Personal communication. |
3) | Hegde BM. Cholesterol Saga. 1995. Doctor Speaks.
Book. Manipal Foundation. |
4) | National Heart Lung and Blood Institute. Facts about blood Cholesterol, 1987. US Dept. of
health and Human Services. |
5) | Kafenak S, Kwitarovich P. Treatment of
hypercholesterlaemia in the elderly. Ann.
Intern. Med. 1990;112:723-726. |
6) | Kannel W, Abbott RD. An update on the Framingham
Study. NEJM 1984; 311: 1144-1147. |
7) | Hubert HB, et. al. A 26-year follow up of the
Framingham Heart Study. Circulation
1983; 67: 968-976. |
8) | Kuller et. al. Primary Prevention of heart Attacks:
The Multiple Risk Factor Interventional Trial.
Amer. Jr. Epidemiol. 1980;112:185-199. |
9) | Lipid Research Clinic Program. Coronary Drug Project trial results: reduction in
the incidence of heart disease. JAMA 1984;
251: 351-364. |
10) | Jacobs D, Blackburn H, Higgins M et al. Report of the conference on low blood
cholesterol: mortality associations. Circulation 1992; 86:1046-1060. |
11) | Shepherd J, Cobbe SM, Isles CG, et al. Prevention of
CAD with pravastatin in men with hypercholesteraemia.
N Engl J Med 1995; 333: 1301-1307. |
12). |
Stephens NG, Parsons A, Schofield PM, et al. Cambridge Heart Antioxidant Study Vitamin E (CHAOS) Lancet 1996; 347: 781-786 |
13) | Marchioli R, Marfisi RM, Carinci F, and Tognoni G.
Meta-analysis, Clinical trials, and Transferability of Research results into practice.
Cholesterol lowering and CAD. Arch.
Int. Med. 1996; 156: 1158-1172. |
14) | Hegde BM.
Need for change in medical paradigm. Proc.
Roy. Coll. Physi.Edinb. 1993; 23:9-12. |